eli lilly and company news

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of notable wins have me thinking this lead will widen. Earli

NBC News on MSN · 13h

Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Reuters on MSN · 1d

Britain to study use of Lilly's weight loss drug to get people back to work

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy. Health minister Wes Streeting predicted the use of the drug - a competitor to Novo Nordisk's Ozempic - could help transform the health of the nation,

Eli Lilly's tirzepatide is off FDA's shortage list

FiercePharma · 2d

In win for compounders, FDA will review its decision to put Eli Lilly's tirzepatide on shortage list

In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities Association (OFA), which called the FDA’s decision to remove tirzepatide from the shortage list a “reckless and arbitrary decision—lacking any semblance of lawful process.”

FOX News on MSN · 11h

Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

NBC News on MSN · 2d

Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.

How Eli Lilly Outpaces Nvidia—Here Is One Chart

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

Pharmaceutical Technology5h

Eli Lilly will ‘build new way of doing science’ in UK amid £297m pledge to government

Lilly’s senior VP of information and R&D IT Ramesh Durvasula said Lilly will use AI and tech to transform the company.

3 Reasons Eli Lilly Stock Isn't Going to Run out of Steam Anytime Soon

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

This Artificial Intelligence Move Is One New Reason to Buy Eli Lilly Stock in 2024

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly ( LLY -1.74%) is taking a shot at developing one. With the appointment of a new ...

Eli Lilly: A Strong Buy on Robust Revenue Growth and Expanding Market Potential

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due ...

Eli Lilly and Company (NYSE:LLY) Shares Up 2.3% – Here’s What Happened

Eli Lilly and Company (NYSE:LLY – Get Free Report) shares rose 2.3% on Tuesday . The company traded as high as $920.28 and ...

2don MSN

Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

1don MSN

Eli Lilly’s Zepbound to undergo first-of-its-kind study on economic impact

Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...

中国日报网20h

Eli Lilly to expand medicine production in China

US pharmaceutical company Eli Lilly and Co recently announced a roughly $200 million expansion of its manufacturing site in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics